Get Involved

Pluripotency, reprogramming and mitochondrial biology

Study Code: 10923

Contact phone number: Research Midwives Office Tel 0191 2820362

What is the aim of this study?

This study is discussed with people who are coming to the fertility centre for treatment.  The researchers aim to improve fertility treatment in the future and also help to find cures for many serious illnesses and diseases.  This research also hopes to develop new research tools.

What do people in this study have to do?

People who take part in this study will be asked to donate eggs and follicular fluid, sperm or embryos that are not needed for their treatment and would otherwise be disposed of.  They will also be asked to give a small blood sample.

What are the risks and benefits for women taking part in this research study?

Taking part in this research study will have no direct benefit on the people involved, but it is hoped that this research will lead to the new scientific insights and treatments that will be of benefit to people in the future.

This research study is due to end 01/11/2015

Clinical Trials in Reproductive Health and Childbirth

Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.

Pluripotency, reprogramming and mitochondrial biology

This research aims to improve fertility treatment in the future and also help to find cures for many serious illnesses and diseases.

Uteroplacental Tissue Bank.

This study involves looking at cells from the uterus (womb), cervix and placenta (afterbirth) in order to understand how these cells work, what controls them and why these control mechanisms sometimes go wrong.


This study aims to find the best method for measuring the amount of protein in the urine to predict diagnosis of pre-eclampsia and how serious the condition is for women.

Reproductive health and childbirth publications from our region

Here you can access journal articles from research carried out here in our region


A large randomised controlled trial in which women undergoing surgery for endometriosis will be randomly allocated to take long acting progestogens. The trial will provide information on which treatment is the most effective in terms of symptom relief, side-effects, acceptability and costs.


CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial

Latest news from PPI

View all